DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
view all Clinical Trials
Overview
This study aims to validate molecular as well as clinical and imaging biomarkers of lung cancer in individuals with indeterminate lung nodules.
Contact
For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.